The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

AKR AKERS BIOSCIENCES, INC. COM SHS NPV




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
12:00 01-Dec-2016 AKR US Distribution Agreement: Cholesterol Self-test RNS -7.30% Down
07:06 28-Nov-2016 AKR Clinical Trial for BreathScan DKA Completed RNS -0.54% Down
07:00 17-Nov-2016 AKR Supplement to Form S-3 Registration Statement RNS -18.88% Down
12:00 14-Nov-2016 AKR Notice of AGM RNS -6.64% Down
07:00 14-Nov-2016 AKR 3rd Quarter Results RNS -6.64% Down
07:00 10-Nov-2016 AKR European Patent Granted RNS -2.71% Down
16:29 09-Nov-2016 AKR Notice of Q3 Results RNS -3.91% Down
07:00 25-Oct-2016 AKR Filing of Form S-3 Registration Statement RNS +1.69% Up
07:00 19-Aug-2016 AKR Settlement of Dispute with ChubeWorkx RNS +5.90% Up
07:00 18-Aug-2016 AKR Results of OxiChek Test Study RNS +5.26% Up
07:00 11-Aug-2016 AKR Half Yearly Results RNS +6.05% Up
16:00 09-Aug-2016 AKR Notice of H1 2016 Earnings RNS +3.26% Up
07:00 30-Jun-2016 AKR Clinical Trial for Rapid Chlamydia Test Completed RNS +38.44% Up
07:00 27-Jun-2016 AKR Distribution Agreement for BreathScan OxiChekT RNS +25.26% Up
12:00 14-Jun-2016 AKR Issue of Equity & PDMR Shareholding RNS -1.36% Down
17:10 26-May-2016 AKR PDMR Shareholding RNS +3.40% Up
07:00 12-May-2016 AKR Financial Results for Q1 2016 RNS +8.43% Up
12:00 10-May-2016 AKR Notice of Q1 Results RNS +6.07% Up
12:00 25-Apr-2016 AKR Board Rearrangement RNS -0.80% Down
07:00 30-Mar-2016 AKR Final Results RNS +3.89% Up

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.





Company Information
Updated Monthly
Company address 201 Grove Road, Thorofare, 08086, United States
Company website http://www.akersbioscie...
Market cap(in millions)* £ 8.41
Listing/Admission to trading 22 May 2002
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
09-Dec-16
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Health Care Equipment & Services
FTSE sub-sector Medical Supplies
Country of share register GB
Segment AIM
MiFID Status MTF
Exchange market size 300
SEDOL BGLCYM6
ISIN number US00973E1029



AKERS BIO share news analysis (AKR)